Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04602325 · ClinicalTrials.gov registry record
Systemic Biomarkers of Brain Injury From Hyperammonemia
A clinical trial of Hypoxic Ischemic Encephalopathy and Urea Cycle Disorder, sponsored by Children's National Research Institute.
- Recruiting
- Registry status
- 24
- Enrollment target
- 1
- Study location
NCT04602325 is a study of Hypoxic Ischemic Encephalopathy and Urea Cycle Disorder that is actively recruiting participants, run by Children's National Research Institute. The registered enrollment target is 24 participants, below the 81-participant average among 13 other Hypoxic Ischemic Encephalopathy trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04602325, a study of Hypoxic Ischemic Encephalopathy and Urea Cycle Disorder, is actively recruiting participants, sponsored by Children's National Research Institute.
- RECRUITING
- Registry status
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Ammonia is a waste product of protein and amino acid catabolism and is also a potent neurotoxin. High blood ammonia levels on the brain can manifest as cytotoxic brain edema and vascular compromise leading to intellectual and developmental disabilities. The following aims are proposed: Aim 1 of this study will be to determine the chronology of biomarkers of brain injury in response to a hyperammonemic (HA) brain insult in patients with an inherited hyperammonemic disorder. Aim 2 will be to determine if S100B, NSE, and UCHL1 are altered in patients with two other inborn errors of metabolism, Maple Syrup Urine Disease (MSUD) and Glutaric Acidemia (GA1).
Conditions Studied
Study Locations (1)
District of Columbia
- Children's National Research Institute - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2020-07-09 |
| Est. Completion | 2027-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04602325
The ClinicalTrials.gov registry entry for NCT04602325 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 81-participant average among 13 other Hypoxic Ischemic Encephalopathy trials with a reported enrollment target (70% lower). The listed sponsor is Children's National Research Institute, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Hypoxic Ischemic Encephalopathy appearing as the primary indexed condition, and to 0 interventions.
NCT04602325 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04602325 about?
NCT04602325 is a clinical study titled "Systemic Biomarkers of Brain Injury From Hyperammonemia". Ammonia is a waste product of protein and amino acid catabolism and is also a potent neurotoxin. High blood ammonia levels on the brain can manifest as cytotoxic brain edema and vascular compromise leading to intellectual and developmental disabilities. The following aims are proposed: Aim 1 of thi...
What is the current status of trial NCT04602325?
This trial is currently recruiting. The enrollment target is 24 participants. The study started on 2020-07-09. Estimated completion is 2027-05.
What conditions does trial NCT04602325 study?
This clinical trial studies the following conditions: Hypoxic Ischemic Encephalopathy, Urea Cycle Disorder, Organic Acidemia, Maple Syrup Urine Disease, Glutaric Acidemia I.
Who is sponsoring clinical trial NCT04602325?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04602325 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoxic Ischemic Encephalopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The HIEnome Study: Genome Sequencing for Perinatal HIE
RECRUITING · NA
-
Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia
RECRUITING · Early Phase 1
-
Dose Optimization of Caffeine for HIE
RECRUITING · Phase 1
-
Healthy Little Eyes
RECRUITING
-
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
RECRUITING · NA
-
Spinal Stimulation and Mobility Devices
RECRUITING · NA
Explore more on PlainTrial
Hypoxic Ischemic Encephalopathy
All registered trials for this condition
Urea Cycle Disorder
All registered trials for this condition
District of Columbia
All trials with a study site in District of Columbia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.